Novel Therapies for Type 2 Diabetes and Obesity Summit

Key Topics

• Disease-Modifying Targets to Sustainably Transform Glycaemic Control
• Therapies to Rival Bariatric Surgery
• GLP-1 Receptor Agonists & Beyond: Exploring Radical Progress of Oral Incretins in the Clinic
• Diabetic Complications to Reduce Mortality in Metabolic Disorders
• Development
• Biomarkers to Diagnose & Monitor Diabetes & Predict Non- Responsers to Optimize Therapeutic
• Models & Holistic Approaches to Drug Discovery to Better Recapitulate Disease Pathogenesis & Multiple Cardiometabolic Pathologies
• Approaches to Set Point Theory & Understanding of Multiple Etiologies to Forge a New Era of Sustainable Weight Loss
• Opportunities for Drug-Based Management of Obesity & Type 2 Diabetes
• Outcome Trials & Commercial Strategy to Optimize the Pathway to Market